Fusion-Negative Sarcoma Survivors Have Increased Risk of Second Malignancies

Fusion-Negative Sarcoma Survivors Have Increased Risk of Second Malignancies Dave Levitan | August 4, 2016 | CancerNetwork | See Original Here Survivors of fusion-negative (F−) sarcomas have a higher risk of developing a second malignant neoplasm than those who had fusion-positive (F+) sarcomas, according to a new study, which could offer guidance on surveillance of these…
Continue Reading »

Tracking Cancer In Real Time

Tracking Cancer In Real Time By Anna Gorman | July 21, 2016 | Kaiser Health News | See Original Here California is overhauling the way it collects information for its massive cancer database in the hope of improving how patients are treated for the disease. Pathologists at a dozen hospitals in the state are part of a pilot…
Continue Reading »

Clinical studies of PBS protons

Clinical studies of PBS protons Cynthia E Keen | MedicalPhysicsWeb | July 19, 2016 | See Original Here Switzerland's Paul Scherrer Institute (PSI) developed the technique of pencil-beam scanning (PBS) proton therapy 20 years ago and continues to be a pioneering global leader in its use. In newly published studies, researchers at PSI's Center for…
Continue Reading »

‘Liquid biopsy’ may show whether cancer drugs are working

'Liquid biopsy' may show whether cancer drugs are working Amy Norton | HealthDay News | July 13, 2016 | From UPI News | See Original Here Researchers have developed a blood test that might allow doctors to know quickly whether a cancer drug is working. The technique is in the early stages of testing, and not…
Continue Reading »

Cancer cell lines predict drug response and accelerate personalized medicine

Cancer cell lines predict drug response and accelerate personalized medicine July 7, 2016 | ScienceDaily | See Original Here Source: Wellcome Trust Sanger Institute Summary: Research has shown that patient-derived cancer cell lines harbor most of the same genetic changes found in patients' tumors, and could be used to learn how tumors are likely to respond to new…
Continue Reading »

FDA Panel Endorses Early Trials of Promising Anticancer Agents in Pediatric Patients

FDA Panel Endorses Early Trials of Promising Anticancer Agents in Pediatric Patients  Jason M. Broderick @jasoncology | Published Online OncLive |  Wednesday, Jun 29, 2016 | See Original Here Members of the Pediatric Subcommittee of the FDA’s Oncologic Drugs Advisory Committee (pedsODAC) voiced their support for new clinical trials examining promising cancer agents in pediatric patients. Albert S.…
Continue Reading »

Cancer breakthrough as scientists discover new ways of blocking potentially lethal tumours spreading around the body Read more: http://www.dailymail.co.uk/health/article-3655880/Cancer-breakthrough-scientists-discover-new-ways-blocking-potentially-lethal-tumours-spreading-body.html#ixzz4COxiII2C Follow us: @MailOnline on Twitter | DailyMail on Facebook

Cancer breakthrough as scientists discover new ways of blocking potentially lethal tumours spreading around the body STEPHEN MATTHEWS | Daily Mail Online | June 23, 2016 | See Original Here Metastasis long been a mystery to scientists, but new findings offer hope  'Free floating' cells currently survive due to proteins called integrins Integrins pair with another…
Continue Reading »

Advances in cancer will only happen through true collaboration

Advances in cancer will only happen through true collaboration By Nancy G. Brinker and Eric T. Rosenthal, contributors | June 20, 2016 | The Hill | See Original Here Getty Images After some three decades attending the American Society of Clinical Oncology (ASCO) annual meeting — the world's largest gathering of cancer professionals — we've seen…
Continue Reading »

Could This Breakthrough Change Everything We Know About Treating Cancer?

Could This Breakthrough Change Everything We Know About Treating Cancer? Todd Campbell | Motley Fool | June 18, 2016 | See Original Here Beginning with blood cancers, these companies are developing next generation cancer killers that could reshape cancer treatment. IMAGE SOURCE: JUNO THERAPEUTICS Researchers at Juno Therapeutics (NASDAQ:JUNO) and Kite Pharma (NASDAQ:KITE) have released…
Continue Reading »

Stanford scientists create ‘guided chemotherapy missiles’ that target cancer cells and spare healthy ones

Stanford scientists create ‘guided chemotherapy missiles’ that target cancer cells and spare healthy ones By Amy Adams | Stanford News | June 16, 2016 | See Original Here Latching chemotherapy drugs onto proteins that seek out tumors could provide a new way of treating tumors in the brain or with limited blood supply that are…
Continue Reading »
Skip to toolbar